Pharmacology Presentation Drugs Practice Test

Does Ocrelizumab cure MS?

Yes No Only in some patients It depends on the subtype

Correct Answer:

Explanation:

Understanding the question hinges on the difference between a cure and a disease-modifying therapy. Ocrelizumab targets CD20-positive B cells to dampen the autoimmune attack on myelin, which reduces relapse rates and slows disability progression in both relapsing-remitting MS and primary progressive MS. This proves its effectiveness at controlling disease activity, but it does not eradicate MS or permanently restore lost neurological function. MS remains a chronic condition that can reactivate if therapy is stopped, and no treatment has been proven to cure the disease. So, while ocrelizumab can significantly reduce activity and progression, it is not a cure.

Access more questions from this quiz

Continue to Pharmacology Presentation Drugs Practice Test for more practice questions and the full quiz experience.

Access More Questions